TRIPS Waiver: Pembelajaran dari Pandemi Covid-19
Article Sidebar
Main Article Content
Abstract
Penelitian ini mengkaji dampak TRIPS (Agreement on Trade-Related Aspects of Intellectual Property Rights) terhadap sektor farmasi dan teknologi serta relevansinya dengan TRIPS Waiver dalam mengatasi pandemi Covid-19. TRIPS merupakan perjanjian multilateral yang ditandatangani oleh anggota Organisasi Perdagangan Dunia (WTO) pada tahun 1994, yang memberikan perlindungan hak paten obat selama minimal 20 tahun. Namun, hal ini mempengaruhi akses negara-negara berkembang terhadap obat-obatan dengan harga terjangkau. Di tengah pandemi Covid-19, beberapa negara berkembang, seperti India dan Afrika Selatan, mengajukan proposal TRIPS Waiver untuk mencabut sementara perlindungan hak kekayaan intelektual (HKI) terkait teknologi Covid-19. Tulisan ini menggunakan metode penelitian yuridis normatif dan analisis data deduktif untuk membahas pengaruh TRIPS dan implikasi TRIPS Waiver dalam mengatasi krisis kesehatan global.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Carlos M. Correa, Intellectual Property Rights, The WTO and Developing Countries: The TRIPS and Policy Options, (Penang, Malaysia: Third World Network, 2000)
Canadian Centre for Policy Alternatives.. Civil Society Letter Supporting India’s and South Africa’s Proposal for a TRIPS Waiver for COVID-19 Treatments” 2021.;
Dianne Nicol & Olasupo Owoeye, “Using TRIPS Flexibilities to Facilitate Access to Medicines”, Bull World Health Organ, 91(7); 2013
European Jurnal of International Law. Analysis of the 12th WTO Ministerial Conference Decision on the TRIPS Agreement
Harris P. Donald, “TRIPS' Rebound: An Historical Analysis of How the TRIPS Can Ricochet back against the United States”, Northwerstern Journal of International Law & Business, Vol. 25, No. 99, 2004.
Hertanti, H., Prakoso, A. Hertanti, H., Prakoso, “Hentikan Monopoli HAKI Terhadap Covid 19 Laksanakan TRIPs Waiver, J,” Indonesia For Global Justice, 2021
Johns Hopkins Bloomberg School of Public Health. WTO TRIPS Waiver for COVID-19 Vaccines
Matthews, D. (2004). WTO Decision on Implementation of paragraph 6 of the DOHA Declaration on the TRIPs agreement and Public Health: a solution to the access to essential medicines problem? Journal of International Economic Law, 7(1), 73.
OxFAM International. WTO agrees a deal on patents for COVID vaccines - but campaigners say this is absolutely not the broad intellectual property waiver the world desperately need
Peraturan Presiden Nomor 101 Tahun 2021 tentang Pelaksanaan Paten oleh Pemerintah terhadap Obat Favipavir
Sarah Diva, et.al” Usulan Pengabaian Hak Paten Vaksin Covid-19 Dalam Perspektif Hukum Internasional”, Jurnal Kertha Desa, Vol. 10 No. 10
So, A. D., & Woo, J. (2021, April). Achieving path-dependent equity for global COVID-19 vaccine allocation. Med, 2(4)
Undang Undang No. 16 Tahun 2013 tentang Paten
Utomo, Tomi Suryo, “Eksistensi “The Trips Safeguards” di dalam Perjanjian TRIPS: Dalam Perspektif Kesehatan Masyarakat”, Mimbar Hukum, Vol 20, No 2 (2008)
World Trade Organization. Understanding on Rules and Procedures Governing the Settlement of Disputes. Geneva: World Trade Organization
World Trade Organization . WTO Ministrial Conference Decision on TRIPS Agreement
World Trade Organization. Trade Related Intelectual Property Rights Agreement.
World Healt Organization. 2022 can mark the end of COVID's acute stage
Zainuddin Ali, Metode Penelitian Hukum, Jakarta: Sinar Grafika, 2016